FindTrial
Sign In

The diagnosis value of red blood cell distribution width in patients with colorectal cancer

The diagnosis value of red blood cell distribution width in patients with colorectal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000031726
Enrollment
Unknown
Registered
2020-04-08
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

Gold Standard:Pathological examination
Index test:red&#32
blood&#32
cell&#32
distribution&#32
width

Sponsors

People's Hospital of Deyang City
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Pathologically confirmed colorectal cancer patients admitted to deyang people's hospital between May 2018 and April 2020.

Exclusion criteria

Exclusion criteria: 1)Patients with anemia, hematologic disorder; 2)Receiving iron deficiency treatment; 3) Active inflammation; 4) Blood transfusion made in the last three months.

Design outcomes

Primary

MeasureTime frame
Red blood cell distribution width;SEN, SPE, ACC, AUC of ROC;—

Secondary

MeasureTime frame
Carcinoembryonic antigen;CA-199;—

Countries

China

Contacts

Public ContactMingran Zhang

Department of Gastrointestinal Surgery, People's Hospital of Deyang City

zhangmingran1991@163.com+86 15828052455

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026